Results 81 to 90 of about 12,319,026 (249)

High-sensitive cardiac troponin T.

open access: yesJournal of geriatric cardiology : JGC, 2013
Cardiac troponin is the preferred biomarker for the diagnosis of acute myocardial infarction (AMI). The recent development of a high-sensitive cardiac troponin T (hs-cTnT) assay permits detection of very low levels of cTnT. Using the hs-cTnT assay improves the overall diagnostic accuracy in patients with suspected AMI, while a negative result also has ...
Xu, Ru-Yi   +3 more
openaire   +2 more sources

Nanoparticulate Copper Cluster-Mediated Biosensing of Cardiac Biomolecular Markers

open access: yesBiosensors
Being a leading cause of death, heart diseases across the globe need special attention to enable early diagnosis. Metal nanoparticle-mediated biosensors are useful clinical tools for the early detection of bio-analytes. The size-dependent surface plasmon
Lakshmi V. Nair   +5 more
doaj   +1 more source

High-sensitivity cardiac troponin T and copeptin assays to improve diagnostic accuracy of exercise stress test in patients with suspected coronary artery disease [PDF]

open access: yes, 2014
Background: The average diagnostic sensitivity of exercise stress tests (ESTs) is lower than that of other non-invasive cardiac stress tests. The aim of the study was to examine whether high-sensitivity cardiac troponin T (hs-cTnT) or copeptin ...
Dörr, Oliver   +9 more
core   +1 more source

Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay

open access: yesCanadian Medical Association Journal, 2015
Background: We aimed to prospectively validate a novel 1-hour algorithm using high-sensitivity cardiac troponin T measurement for early rule-out and rule-in of acute myocardial infarction (MI).
T. Reichlin   +28 more
semanticscholar   +1 more source

Biosensors for cardiac biomarkers detection: a review [PDF]

open access: yes, 2012
The cardiovascular disease (CVD) is considered as a major threat to global health. Therefore, there is a growing demand for a range of portable, rapid and low cost biosensing devices for the detection of CVD.
Gurbuz, Yasar   +3 more
core   +1 more source

Diagnostic accuracy of single baseline measurement of Elecsys Troponin T high-sensitive assay for diagnosis of acute myocardial infarction in emergency department: systematic review and meta-analysis

open access: yesBritish medical journal, 2015
Objective To obtain summary estimates of the accuracy of a single baseline measurement of the Elecsys Troponin T high-sensitive assay (Roche Diagnostics) for the diagnosis of acute myocardial infarction in patients presenting to the emergency department.
Z. Zhelev   +8 more
semanticscholar   +1 more source

Development of Optical Biosensor Technologies for Cardiac Troponin Recognition [PDF]

open access: yes, 2015
Acute myocardial infarction (AMI) is the leading cause of death among cardiovascular diseases. Among the numerous attempts to develop coronary marker concepts into clinical strategies, cardiac troponin is known as a specific marker for coronary events ...
Abdolrahim, Mojgan   +5 more
core   +1 more source

ST2 and Multimarker Testing in Acute Decompensated Heart Failure [PDF]

open access: yes, 2015
Most data on heart failure biomarkers have been derived from patient cohorts with chronic disease. However, risk prediction in patients admitted with acute decompensated heart failure (ADHF) remains a challenge.
Antoni, Md   +7 more
core   +1 more source

Diagnostic Value of Troponin I and T to Predict Mortality in Patients Undergoing Hemodialysis

open access: yesArchives of Anesthesia and Critical Care, 2018
Background: There is no known biomarker to predict the mortality risk in patients undergoing dialysis in the intensive care unit (ICU). Therefore, the current study aimed to determine the diagnostic value of troponin I and T in this respect.
Seyed Taghi Hashemi   +2 more
doaj  

Cardiac troponin T as a serum biomarker of respiratory impairment in amyotrophic lateral sclerosis

open access: yesAnnals of Clinical and Translational Neurology
Objective Informative biomarkers are an urgent need in the management of amyotrophic lateral sclerosis. Serum cardiac troponin T is elevated in the majority of amyotrophic lateral sclerosis patients and increases with disease progression.
Teresa Koch   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy